Angela Dispenzieri, MD, Mayo Clinic, Rochester, MN
Category Archives: Myeloma & Amyloidosis
CAR-T in 2025: Advancements and the Road Ahead
Jason Westin, M.D., MS, FACP, MD Anderson Cancer Center, Houston, TX
Highlights from Attending ASH 2024
Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY
Highlights from Attending the 2024 Society of Hematologic Oncology (SOHO) Annual Meeting
Shira Dinner, MD, Northwestern University, Chicago, IL and Tom Martin, MD, University of California San Francisco, San Francisco, CA
Highlights from attending the 2023 ASH Annual Meeting
Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY
The Role of the Primary Care Physician in Treating Chronic Blood Cancers: Focus on Myeloma
Zalman Suldan, MD, PhD, Hackensack University Medical Center – Hackensack Meridian Health, Hackensack, NJ